Corbus Pharmaceuticals Holdings CRBP
NASDAQ CRBP
$4.05 -0.08 (-1.94%)
At close: Oct 23, 2026 · 4:00 PM EDT

Corbus Pharmaceuticals Holdings (CRBP) Asset Writedowns and Impairment (2021)

Updated

Corbus Pharmaceuticals Holdings' Asset Writedowns and Impairment came in at $606,000 for Q3 2021.

Analysis

Corbus Pharmaceuticals Holdings (CRBP) Asset Writedowns and Impairment (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Corbus Pharmaceuticals Holdings 49.84 Mn -466.79 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 606,000.00
API Access

Corbus Pharmaceuticals Holdings Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=CRBP&period=max&api_key=YOUR_API_KEY